STEREOTACTIC FINE-NEEDLE BIOPSY IN 2594 MAMMOGRAPHICALLY DETECTED NON-PALPABLE LESIONS

[1]  G. Auer,et al.  Nuclear DNA Content, Histological Grade, and Clinical Course in Patients with Nonpalpable Mammographically Detected Breast Adenocarcinomas , 1990, American journal of clinical oncology.

[2]  T. Landberg,et al.  Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. , 1988, BMJ.

[3]  F. Hall,et al.  Nonpalpable breast lesions: recommendations for biopsy based on suspicion of carcinoma at mammography. , 1988, Radiology.

[4]  L. Tabár,et al.  REDUCTION IN MORTALITY FROM BREAST CANCER AFTER MASS SCREENING WITH MAMMOGRAPHY Randomised Trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare , 1985, The Lancet.

[5]  J. Hendriks,et al.  REDUCTION OF BREAST CANCER MORTALITY THROUGH MASS SCREENING WITH MODERN MAMMOGRAPHY First Results of the Nijmegen Project, 1975 - 1981 , 1984, The Lancet.

[6]  C. Silfverswärd,et al.  Stereotaxic Needle Biopsy of Non-Palpable Breast Lesions , 1983, Acta radiologica: diagnosis.

[7]  G. Svane.  A Stereotaxic Technique for Preoperative Marking of Non-Palpable Breast Lesions , 1983, Acta radiologica: diagnosis.

[8]  S. Shapiro,et al.  Ten- to fourteen-year effect of screening on breast cancer mortality. , 1982, Journal of the National Cancer Institute.

[9]  Breast cancer screening with mammography: a population-based, randomized trial with mammography as the only screening mode. , 1979, Radiology.

[10]  W. Logan.  Breast carcinoma : the radiologist's expanded role , 1977 .

[11]  M. Moskowitz,et al.  On the diagnosis of minimal breast cancer in a screenee population , 1976, Cancer.